How addressing unnecessary device alarms and managing them away from the bedside can help patients heal and nurses focus Hospital noise levels have skyrocketed since the 1960s, turning patient rooms — especially at night — into spaces of fragmented sleep…
Presented by:
Most health care organizations struggle with fragmented systems that make it difficult to share patient information and operate efficiently. Optum Health faced this challenge head-on — transforming dozens of standalone EHR systems into a single enterprise platform. This transformation unified…
Presented by:
Jonathan Cooper
Vice President, Provider Technology Consulting, Optum consulting
Lucas Ladden
Vice President, Practice Innovation, Strategy, and Operations, Optum Health
From NCI-designated cancer center directors and to endowed chairs, here are 11 health systems seeking leaders for oncology services:
Far Rockaway, N.Y.-based Episcopal Health Services has opened a cancer center within the system’s Walsh Ambulatory Pavilion. The EHS Cancer Center will provide medical and radiation oncology care, while surgical oncology services will remain at St. John’s Episcopal Hospital, located…
Of the $19.297 billion the National Institutes of Health awarded to 145 medical schools in fiscal 2025, about 3.43% was given to radiation or diagnostic oncology departments, according to data published by the Blue Ridge Institute for Medical Research. Philadelphia-based…
Seattle-based Fred Hutch Cancer Center has named Holly Harris, PhD, the inaugural Bus Family Endowed Chair. The endowed chair will support research in prevention, early detection and precision oncology related to uterine, ovarian and breast cancers, according to a Feb.…
The FDA has placed a partial clinical hold on a cancer drug trial following four safety events, including one death, according to a Feb. 25 announcement from MacroGenics. The partial hold pauses enrollment for MacroGenics’ phase 2 study on lorigerlimab, an experimental…
Pfizer received full FDA approval for its Braftovi (encorafenib) combination regimen as a first-line treatment for adult patients with BRAF V600E-mutant metastatic colorectal cancer. The approval covers Braftovi in combination with cetuximab and fluorouracil-based chemotherapy, including mFOLFOX6 and FOLFIRI, according…
Kansas City-based University of Kansas Cancer Center has established a research program to study the link between obesity, metabolic health and cancer. KU Cancer Center’s Obesity, Metabolic Health and Cancer Research Program will develop exercise, nutrition and pharmacological interventions to…
Philadelphia-based Fox Chase Cancer Center has appointed David Weinberg, MD, as vice president and physician lead of the cancer screening and prevention service line. Dr. Weinberg will also serve as the associate director of cancer screening and prevention at the…
